CXCL1 and inflammatory bowel disease: CAR-Ms can also secrete CXCL1 and WNT, which coordinate the regeneration of damaged intestinal epithelial cells, offering a potential treatment for inflammatory bowel disease (IBD) (Na et al., 2021).